Declaration of quarterly results from the first sun pharmaceutical industries share of increased business today. NSE in 2 per cent share of the company with to steer India toward Rs. 712. According to the estimates of the world. Sun Pharma consolidated net profit of 30 September 2012 as an end to 29 per cent in the second quarter can be increased 772 crore rupees. In the same period last year the company earned a profit of Rs 598 crore.